Patents by Inventor Hugo Albrecht

Hugo Albrecht has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060177432
    Abstract: The invention discloses a protease inhibitor and a method of inhibiting a protease selected from the group consisting of thrombin, chymotrypsin and neuropsin, by contacting the protease with an effective amount of a member of the phosphoethanolamine binding protein (PEBP) family.
    Type: Application
    Filed: December 19, 2005
    Publication date: August 10, 2006
    Inventors: Hugo Albrecht, Ulrich Hengst, Denis Monard
  • Patent number: 7029877
    Abstract: There is provided a protease inhibitor and a method of inhibiting a protease selected from the group consisting of thrombin, chymotrypsin and neuropsin, by contacting the protease with an effective amount of a member of the phosphoethanolamine binding protein (PEBP) family.
    Type: Grant
    Filed: August 30, 2001
    Date of Patent: April 18, 2006
    Assignee: Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Instittue for Biomedical Research
    Inventors: Hugo Albrecht, Ulrich Hengst, Denis Monard
  • Publication number: 20050037009
    Abstract: There is provided a protease inhibitor and a method of inhibiting a protease selected from the group consisting of thrombin, chymotrypsin and neuropsin, by contacting the protease with an effective amount of a member of the phosphoethanolamine binding protein (PEBP) family.
    Type: Application
    Filed: August 30, 2001
    Publication date: February 17, 2005
    Inventors: Hugo Albrecht, Ulrich Hengst, Denis Monard
  • Publication number: 20050019261
    Abstract: Animal models and screening methods are provided useful for the identification of modulators of neuronal activity and plasticity, as well as for diagnostic purposes. The methods are based on the use of a serine protease inhibitor, in particular PN-1, as an indicator of neuronal activity.
    Type: Application
    Filed: November 29, 2002
    Publication date: January 27, 2005
    Inventors: Hugo Albrecht, Mirna Kvajo, Denis Monard